Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Gains from Sales and Divestitures (2024 - 2025)

Historic Gains from Sales and Divestitures for iSpecimen (ISPC) over the last 2 years, with Q3 2025 value amounting to $382.0.

  • iSpecimen's Gains from Sales and Divestitures fell 7808.38% to $382.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $382.0, marking a year-over-year decrease of 7808.38%. This contributed to the annual value of $1800.0 for FY2024, which is N/A changed from last year.
  • iSpecimen's Gains from Sales and Divestitures amounted to $382.0 in Q3 2025, which was down 7808.38% from $338.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Gains from Sales and Divestitures ranged from a high of $1800.0 in Q4 2024 and a low of $152.0 during Q1 2025